For patients with minimally active or inactive uveitis and persistent or recurrent uveitic macular edema (ME), dexamethasone is significantly better for treatment than methotrexate or ranibizumab, ...

A dexamethasone implant significantly outperformed ranibizumab (Lucentis) and methotrexate for intravitreal treatment of persistent/recurrent uveitic macular edema, according to results of a ...

Intravitreal dexamethasone implants stabilized, but did not improve, vision for most patients with macular edema due to retinal vein occlusion (RVO). Intravitreal dexamethasone implants were found to ...

Initial treatment for uveitis-related macular edema seeks to control inflammation and reduce the fluid under the retina. While some patients achieve this goal with oral corticosteroids, most patients ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The first patient has been treated in a phase 2 trial ...

Please provide your email address to receive an email when new articles are posted on . Patients with multiple myeloma who had dexamethasone dose reductions achieved similar PFS and OS as those who ...